HuGE Literature Finder
Records 1-30
|
Distribution of nucleotide variants in the DNA sequence of ERCC1 and XRCC1 genes and the effect of phenotype in patients with gastric cancer.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2019 Jun 30 (6): 517-523. Asgerov Elmir, Senol Özgür, Güler Adem, Berdeli Af |
|
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt.
Medical oncology (Northwood, London, England) 2018 May 35 (6): 83. Formica Vincenzo, Benassi Michaela, Del Vecchio Blanco Giovanna, Doldo Elena, Martano Laura, Portarena Ilaria, Nardecchia Antonella, Lucchetti Jessica, Morelli Cristina, Giudice Emilia, Rossi Piero, Anselmo Alessandro, Sileri Pierpaolo, Sica Giuseppe, Orlandi Augusto, Santoni Riccardo, Roselli Mar |
|
TGF? C-509T, TGF? T869C, XRCC1 Arg194Trp, IKB? C642T, IL4 C-590T Genetic polymorphisms combined with socio-economic, lifestyle, diet factors and gastric cancer risk: A case control study in South Indian population.
Cancer epidemiology 2018 Jan 53 21-26. Pavithra Dhayalan, Gautam Majumdar, Rama Ranganathan, Swaminathan Rajaraman, Gopal Gopisetty, Ramakrishnan Ayyalur Seshadri, Rajkumar Thangaraj |
|
DNA Repair Gene XRCC1 and XPD Polymorphisms and Gastric Cancer Risk: A Case-Control Study Outcome from Kashmir, India.
Analytical cellular pathology (Amsterdam) 2018 2018 3806514. Nissar Bushra, Kadla Showkat A, Khan Nuzhat Shaheen, Shah Idrees A, Majid Misbah, Afshan Falaque Ul, Ganai Bashir Ahm |
|
Analysis of 12 variants in the development of gastric and colorectal cancers.
World journal of gastroenterology 2017 Dec 23 (48): 8533-8543. Cavalcante Giovanna C, Amador Marcos At, Ribeiro Dos Santos André M, Carvalho Darlen C, Andrade Roberta B, Pereira Esdras Eb, Fernandes Marianne R, Costa Danielle F, Santos Ney Pc, Assumpção Paulo P, Ribeiro Dos Santos Ândrea, Santos Sidn |
|
Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
Cancer genetics 2017 Dec 218-219 51-57. Zhang Liping, Zhao Jiangman, Yu Bin, Song Xinjiang, Sun Guogang, Han Lijiang, Wang Lu, Dong S |
|
Pharmacogenetic analysis of the UK MRC MAGIC trial: association of polymorphisms with toxicity and survival in patients treated with perioperative ECF chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct . Smyth Elizabeth, Zhang Shenli, Cunningham David, Wotherspoon Andrew, Soong Richie, Peckitt Clare, Valeri Nicola, Fassan Matteo, Rugge Massimo, Okines Alicia Fc, Allum William, Stenning Sally, Nankivell Matthew, Langley Ruth E, Tan Patri |
|
The XRCC 1 DNA repair gene modifies the environmental risk of stomach cancer: a hospital-based matched case-control study.
BMC cancer 2017 Oct 17 (1): 680. Putthanachote Nuntiput, Promthet Supannee, Hurst Cameron, Suwanrungruang Krittika, Chopjitt Peechanika, Wiangnon Surapon, Chen Sam Li-Sheng, Yen Amy Ming-Fang, Chen Tony Hsiu-H |
|
Colorectal Cancer Carcinogenesis: a Multivariate Genetic Model in a Cohort of Romanian Population.
Clinical laboratory 2017 Apr 63 (4): 647-658. Procopciuc Lucia M, Osian Gelu, Iancu Mihae |
|
Single Nucleotide Polymorphism TGFß1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
International journal of radiation oncology, biology, physics 2017 04 97 (5): 924-930. Smith J Joshua, Wasserman Isaac, Milgrom Sarah A, Chow Oliver S, Chen Chin-Tung, Patil Sujata, Goodman Karyn A, Garcia-Aguilar Jul |
|
X-ray cross-complementing groups 1 rs1799782 C>T polymorphisms and colorectal cancer susceptibility: A meta-analysis based on Chinese Han population.
Journal of cancer research and therapeutics 2016 Dec 12 (Supplement): C264-C267. Wang Liming, Qian Junfeng, Ying Chunxiao, Zhuang Yongwei, Shang Xingjie, Xu Fa |
|
DNA repair genes polymorphisms and risk of colorectal cancer in Saudi patients.
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2016 Sep . Karam Rehab A, Al Jiffry Bilal O, Al Saeed Mohamed, Abd El Rahman Tamer M, Hatem Mohamed, Amer Mona |
|
Gene polymorphism in DNA repair genes XRCC1 and XRCC6 and association with colorectal cancer in Swedish patients.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016 Sep 124 (9): 736-40. Dimberg Jan, Skarstedt Marita, Slind Olsen Renate, Andersson Roland E, Matussek Andre |
|
Investigating the association between XRCC1 gene polymorphisms and susceptibility to gastric cancer.
Genetics and molecular research : GMR 2016 Sep 15 (3): . Chen S, Zhu X C, Liu Y L, Wang C, Zhang K |
|
Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis.
Pharmacogenomics 2016 Sep . Shahnam Adel, Ridha Zainab, Wiese Michael D, Kichenadasse Ganessan, Sorich Michael |
|
ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.
Oncotarget 2016 Jul . Li Ziyu, Xing Xiaofang, Shan Fei, Li Shuangxi, Li Zhongwu, Xiao Aitang, Xing Zhaodong, Xue Kan, Li Zhemin, Hu Ying, Jia Yongning, Miao Rulin, Zhang Lianhai, Bu Zhaode, Wu Aiwen, Ji Jia |
|
Genetic variability of XRCC1 influences the treatment outcome of gastric cancer.
Genetics and molecular research : GMR 2016 Feb 15 (1): . Hu H Q, Wang F, Du X, Zhao X Z, Jin Z, Hou M |
|
Lack of Association between an XRCC1 Gene Polymorphism and Colorectal Cancer Survival in Thailand.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (4): 2055-60. Siewchaisakul Pallop, Suwanrungruang Krittika, Poomphakwaen Kirati, Wiangnon Surapon, Promthet Supann |
|
Variant Alleles in XRCC1 Arg194Trp and Arg399Gln Polymorphisms Increase Risk of Gastrointestinal Cancer in Sabah, North Borneo.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (4): 1925-31. Halim Noor Hanis Abu, Chong Eric Tzyy Jiann, Goh Lucky Poh Wah, Chuah Jitt Aun, See Edwin Un Hean, Chua Kek Heng, Lee Ping-Ch |
|
The relationship between five non-synonymous polymorphisms within three XRCC genes and gastric cancer risk in a Han Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Nov . Gong Huansong, Li He, Zou Jing, Mi Jia, Liu Fang, Wang Dan, Yan Dong, Wang Bin, Zhang Shuping, Tian Ge |
|
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.
The pharmacogenomics journal 2015 Aug . Kjersem J B, Thomsen M, Guren T, Hamfjord J, Carlsson G, Gustavsson B, Ikdahl T, Indrebø G, Pfeiffer P, Lingjærde O, Tveit K M, Wettergren Y, Kure E |
|
Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Aug . Liu Rujiao, Zhao Xiaoying, Liu Xin, Chen Zhiyu, Qiu Lixin, Geng Ruixuan, Guo Weijian, He Guang, Yin Jiliang, Li Jin, Zhu Xiaodo |
|
XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population.
Mutagenesis 2015 May 30 (3): 441-9. Dai Qiong, Luo Hua, Li Xing Pu, Huang Juan, Zhou Tie Jun, Yang Zhi-H |
|
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
|
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.
Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
|
Population stratification effect on cancer susceptibility in an admixed population from Brazilian Amazon.
Anticancer research 2015 Apr 35 (4): 2009-14. Vieira Priscilla Cristina Moura, Burbano Rommel Mario Rodríguez, Fernandes Débora Christina Ricardo Oliveira, Montenegro Raquel Carvalho, Dos Santos Sidney Emanuel Batista, Sortica Vinicius Albuquerque, Assumpção Paulo Pimentel, Ribeiro-Dos-Santos Ândrea Kely Campos, Carvalho Antônio Alberto, Dos Santos Ney Pereira Carnei |
|
DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Mar 36 (3): 1539-48. Zhou Qiang, Zou Bing-Wen, Xu Yong, Xue Jian-Xin, Meng Mao-Bin, Liu Fang-Jiu, Deng Lei, Ma Dai-Yuan, Ao Rui, Lu Y |
|
Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
American journal of clinical oncology 2015 Mar . Osti Mattia F, Nicosia Luca, Agolli Linda, Gentile Giovanna, Falco Teresa, Bracci Stefano, Di Nardo Francesco, Minniti Giuseppe, De Sanctis Vitaliana, Valeriani Maurizio, Maglio Marianna, Borro Marina, Simmaco Maurizio, Enrici Riccardo |
|
XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Feb 36 (2): 461-6. Qin Chang-Jiang, Xu Kai-Wu, Chen Zhi-Hui, Zhai Er-Tao, He Yu-Long, Song Xin-Mi |
|
Association of polymorphisms in X-ray repair cross complementing 1 gene and risk of esophageal squamous cell carcinoma in a Chinese population.
BioMed research international 2015 2015 509215. Yun Yu-Xia, Dai Li-Ping, Wang Peng, Wang Kai-Juan, Zhang Jian-Ying, Xie W |
|
Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (8): 3285-91. Forat-Yazdi Mohammad, Gholi-Nataj Mohsen, Neamatzadeh Hossein, Nourbakhsh Parisa, Shaker-Ardakani Hosse |
|
Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility.
World journal of surgical oncology 2015 13 (1): 244. Huang Yi, Li Xiaohua, He Jing, Chen Lin, Huang Huaxing, Liang Mengdi, Zhu Qiannan, Huang Yaoyu, Wang Li, Pan Chunji, Xia Tianso |
|
XRCC1 Gene Polymorphism, Clinicopathological Characteristics and Stomach Cancer Survival in Thailand.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (14): 6111-6. Putthanachote Nuntiput, Promthet Supannee, Suwanrungruan Krittika, Chopjitt Peechanika, Wiangnon Surapon, Chen Li-Sheng, Yen Ming-Fang, Chen Tony Hsiu-H |
|
Association of XRCC1 gene polymorphisms with susceptibility to gastric cancer in Chinese Han population.
The Journal of pharmacy and pharmacology 2014 Oct 66 (10): 1463-8. Meng Hua, Lu Shuming, Zhang Zhuqing, Chen Meiru, Li Chunyan, Liu Lina, Luan Yo |
|
APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.
World journal of gastroenterology : WJG 2014 Jul 20 (26): 8700-8. Zhang Shi-Heng, Wang Lin-Ang, Li Zheng, Peng Yu, Cun Yan-Ping, Dai Nan, Cheng Yi, Xiao He, Xiong Yan-Li, Wang Do |
|
NAT2, XRCC1 and hOGG1 polymorphisms, cigarette smoking, alcohol consumption and risk of upper aerodigestive tract cancer.
Anticancer research 2014 Jun 34 (6): 3217-24. Marques Cintia Rodrigues, Da Silva Thiago Magalhães, De Albuquerque Dulcineia Martins, Chaves Meiryane Santos, Marques Filho Marcilio Ferreira, Oliveira Jamille Silva, Di Pietro Giuliano, Sousa Sandra Mara Bispo, Simões Aguinaldo Luiz, Rios-Santos Fabríc |
|
XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5637-45. Zhang Xin, Jiang Li-Peng, Yin Yu, Wang Ya- |
|
X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis.
Journal of gastroenterology and hepatology 2014 May 29 (5): 926-33. Wu Hongju, Xu Chongan, Chen Gang, Wang Jing |
|
Association between polymorphisms in XRCC1 gene and treatment outcomes of patients with advanced gastric cancer: a systematic review and meta-analysis.
PloS one 2014 9 (1): e85357. Cao Zhuo, Song Jia, Wang Jun, Guo Xufeng, Yu Shijie, Dong Weig |
|
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
|
Pharmacogenetic role of XRCC1 polymorphisms on the clinical outcome of gastric cancer patients with platinum-based chemotherapy: a systematic review and meta-analysis.
Genetics and molecular research : GMR 2014 13 (1): 1438-46. Xu J, Ma J, Zong H T, Wang S Y, Zhou J |
|
XRCC1 gene polymorphism, diet and risk of colorectal cancer in Thailand.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (17): 7479-86. Poomphakwaen Kirati, Promthet Supannee, Suwanrungruang Krittika, Chopjitt Peechanika, Songserm Nopparat, Wiangnon Surap |
|
XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Cancer biomarkers : section A of Disease markers 2014 14 (6): 449-56. Zhao Dong-Yu, Cheng LiYa, Yu Jian, Shen Ho |
|
Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 2529-38. Mao Dong, Zhang Yun, Lu Hang, Fu Xiaogua |
|
Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?
The pharmacogenomics journal 2013 Oct 13 (5): 423-9. Loh M, Chua D, Yao Y, Soo R A, Garrett K, Zeps N, Platell C, Minamoto T, Kawakami K, Iacopetta B, Soong |
|
Genetic polymorphisms of XRCC1 gene and susceptibility to gastric cancer in Chinese Han population.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2013 Sep 18 (6): 542-6. Lu Zhengmao, Luo Tianhang, Nie Mingming, Bi Jianwei, Ke Chongwei, Xue Xuchao, Ma Liye, Fang Guo |
|
The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays.
Mutation research 2013 Jul 755 (1): 42-8. Gdowicz-Klosok Agnieszka, Widel Maria, Rzeszowska-Wolny Joan |
|
XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.
Molecular biology reports 2013 Jul 40 (7): 4147-51. Tian Zhong, Li Yi-Ling, Liu Jin-Ga |
|
XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
Digestive diseases and sciences 2013 Jul 58 (7): 1880-90. Li Shan, Deng Yan, You Jian-Peng, Chen Zhi-Ping, Peng Qi-Liu, Huang Xia-Mei, Lu Qing-Hua, Huang Xiu-Li, Zhao Jin-Min, Qin X |
|
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer.
Cancer chemotherapy and pharmacology 2013 Jun 71 (6): 1463-72. Cortejoso Lucía, García María I, García-Alfonso Pilar, González-Haba Eva, Escolar Fernando, Sanjurjo María, López-Fernández Luis |
|
Genetic polymorphisms of ERCC1?118, XRCC1?399 and GSTP1?105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin?based adjuvant chemotherapy.
Molecular medicine reports 2013 Jun 7 (6): 1904-11. Liu Yong-Ping, Ling Yang, Qi Qiu-Feng, Zhang Ya-Ping, Zhang Chang-Song, Zhu Chang-Tai, Wang Mei-Hua, Pan Yao-Do |
|
Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.
Medical oncology (Northwood, London, England) 2013 Jun 30 (2): 505. Li Ye, Li Shuying, Wu Zhiwei, Hu Fulan, Zhu Lin, Zhao Xiaojuan, Cui Binbin, Dong Xinshu, Tian Suli, Wang Fan, Zhao Yashua |
|
Association of XRCC1 gene polymorphisms with the survival and clinicopathological characteristics of gastric cancer.
DNA and cell biology 2013 Mar 32 (3): 111-8. Zhang Yangmei, Wang Meilin, Gu Dongying, Wu Dongmei, Zhang Xiaojing, Gong Weida, Tan Yongfei, Zhou Jianwei, Wu Xiaomin, Tang Cuiju, Zhang Zhengdong, Chen Jinf |
|
Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer.
Cancer 2013 Mar 119 (5): 1106-12. Duldulao Marjun P, Lee Wendy, Nelson Rebecca A, Ho Joyce, Le Maithao, Chen Zhenbin, Li Wenyan, Kim Joseph, Garcia-Aguilar Jul |
|
XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.
Cancer chemotherapy and pharmacology 2013 Mar 71 (3): 733-40. Ye Fanghui, Liu Zhenfang, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao |
|
X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Feb 34 (1): 555-63. Zeng Fu-Ren, Ling Yang, Yang Jie, Tian Xiao-Cai, Yang Xin, Luo Rong-Che |
|
Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.
Cancer investigation 2013 Jan 31 (1): 24-8. Lv Hongying, Li Qicai, Qiu Wengsheng, Xiang Jinyu, Wei Hongjun, Liang Hua, Sui Aihua, Liang J |
|
Meta-analysis demonstrates association of XRCC1 genetic polymorphism Arg399Gln with esophageal cancer risk in the Chinese population.
Genetics and molecular research : GMR 2013 Jan 12 (AOP): AOP. Zhang ZY, Xuan Y, Jin XY, Tian X, Wu R |
|
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.
Cancer chemotherapy and pharmacology 2013 Jan . Lee KH, Chang HJ, Han SW, Oh DY, Im SA, Bang YJ, Kim SY, Lee KW, Kim JH, Hong YS, Kim TW, Park YS, Kang WK, Shin SJ, Ahn JB, Kang GH, Jeong SY, Park KJ, Park JG, Kim TY |
|
Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population.
International journal of biological sciences 2013 9 (7): 753-8. Qiao Wen, Wang Tao, Zhang Li, Tang Qing, Wang Dan, Sun Hongk |
|
Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
Onkologie 2013 36 (6): 335-40. Ji Mei, Xu Bin, Jiang Jing-Ting, Wu Jun, Li Xiao-Dong, Zhao Wei-Qing, Zhang Hong-Yu, Zhou Wen-Jie, Wu Chang-Pi |
|
The XRCC1 Arg399Gln gene polymorphism and risk of colorectal cancer: a study in Kashmir.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (11): 6779-82. Khan Nighat Parveen, Pandith Arshad Ahmad, Yousuf Adfar, Khan Nuzhat Shaheen, Khan Mosin Saleem, Bhat Imtiyaz Ahmad, Nazir Zahoor Wani, Wani Khursheed Alam, Hussain Mahboob Ul, Mudassar Sy |
|
Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies.
Molecular biology reports 2012 Dec . Liu L, Miao L, Ji G, Qiang F, Liu Z, Fan Z |
|
Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
Genetics and molecular research : GMR 2012 11 (4): 4. Liu BM, Liu TM, You BS, You HY, Yang J, Li L, He YC |
|
Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.
Pathology oncology research : POR 2012 Oct 18 (4): 1009-14. Lv Hongying, Li Qicai, Qiu Wengsheng, Xiang Jinyu, Wei Hongjun, Liang Hua, Sui Aihua, Liang J |
|
Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population.
Hepato-gastroenterology 2012 Jun 59 (116): 977-80. Liu Yang, Chen Haihui, Chen Limin, Hu Chunho |
|
DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Cancer epidemiology 2012 Apr 36 (2): 183-9. Reeves Stuart G, Meldrum Cliff, Groombridge Claire, Spigelman Allan, Suchy Janina, Kurzawski Grzegorz, Lubinski Jan, Scott Rodney |
|
Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis.
Molecular biology reports 2012 Feb 39 (2): 1305-13. Chen Bo, Zhou Yong, Yang Ping, Wu Xiao-Ti |
|
The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer.
Molecular biology reports 2012 Jan 39 (1): 527-34. Gil Justyna, Ramsey Dave, Stembalska Agnieszka, Karpinski Pawel, Pesz Karolina A, Laczmanska Izabela, Leszczynski Przemyslaw, Grzebieniak Zygmunt, Sasiadek Maria Malgorza |
|
X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.
International journal of radiation oncology, biology, physics 2012 Jan 82 (1): 138-44. Lamas Maria J, Duran Goretti, Gomez Antonio, Balboa Emilia, Anido Urbano, Bernardez Beatriz, Rana-Diez Pablo, Lopez Rafael, Carracedo Angel, Barros Francis |
|
ADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 2139-44. Wen Yuan-Yuan, Pan Xiong-Fei, Loh Marie, Tian Zhi, Yang Shu-Juan, Lv Si-Han, Huang Wen-Zhi, Huang He, Xie Yao, Soong Richie, Yang Chun-X |
|
Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (11): 5721-4. Gan Yi, Li Xiao-Rong, Chen Dao-Jin, Wu Jun-H |
|
Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (2): 665-9. Zhao Yi, Deng Xin, Wang Zhen, Wang Qiang, Liu Yix |
|
MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer.
Genetics and molecular research : GMR 2012 11 (3): 2315-20. Muñiz-Mendoza R, Ayala-Madrigal M L, Partida-Pérez M, Peregrina-Sandoval J, Leal-Ugarte E, Macías-Gómez N, Peralta-Leal V, Meza-Espinoza J P, Moreno-Ortiz J M, Ramírez-Ramírez R, Suárez-Villanueva S, Gutiérrez-Angulo |
|
Polymorphisms of XRCC1 and ADPRT genes and risk of noncardia gastric cancer in a Chinese population: a case-control study.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (11): 5637-42. Pan Xiong-Fei, Xie Yao, Loh Marie, Yang Shu-Juan, Wen Yuan-Yuan, Tian Zhi, Huang He, Lan Hui, Chen Feng, Soong Richie, Yang Chun-X |
|
Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (4): 1553-6. Dogan Mutlu, Karabulut Halil G, Tukun Ajlan, Demirkazik Ahmet, Utkan Gungor, Yalcin Bulent, Dincol Dilek, Akbulut Hakan, Icli Fik |
|
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
The pharmacogenomics journal 2011 Dec 11 (6): 437-43. Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez |
|
Genetic Polymorphisms of XRCC1, Alcohol Consumption, and the Risk of Colorectal Cancer in Japan.
Journal of epidemiology / Japan Epidemiological Association 2011 Dec . Yin G, Morita M, Ohnaka K, Toyomura K, Hamajima N, Mizoue T, Ueki T, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Terasaka R |
|
Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
International journal of radiation oncology, biology, physics 2011 Dec 81 (5): 1319-27. Páez David, Salazar Juliana, Paré Laia, Pertriz Lourdes, Targarona Eduardo, del Rio Elisabeth, Barnadas Agusti, Marcuello Eugenio, Baiget Montserr |
|
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group.
Cancer chemotherapy and pharmacology 2011 Oct 68 (4): 863-70. Yoon H H, Catalano P, Gibson M K, Skaar T C, Philips S, Montgomery E A, Hafez M J, Powell M, Liu G, Forastiere A A, Benson A B, Kleinberg L R, Murphy K |
|
No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.
Cancer epidemiology 2011 Oct 35 (5): e38-41. Gsur Andrea, Bernhart Kathrin, Baierl Andreas, Feik Elisabeth, Führlinger Gerhard, Hofer Philipp, Leeb Gernot, Mach Karl, Micksche Micha |
|
Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.
Arhiv za higijenu rada i toksikologiju 2011 Sep 62 (3): 207-14. Engin Ayse Basak, Karahalil Bensu, Karakaya Ali Esat, Engin Atil |
|
DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Annals of surgical oncology 2011 Sep 18 (9): 2688-98. Ott Katja, Rachakonda P Sivaramakrishna, Panzram Benjamin, Keller Gisela, Lordick Florian, Becker Karen, Langer Rupert, Buechler Markus, Hemminki Kari, Kumar Raj |
|
Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Current medical research and opinion 2011 Jul 27 (7): 1295-302. Canbay Emel, Cakmakoglu Bedia, Zeybek Umit, Sozen Seyma, Cacina Canan, Gulluoglu Mine, Balik Emre, Bulut Turker, Yamaner Sumer, Bugra Durs |
|
DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.
Carcinogenesis 2011 Jun 32 (6): 882-7. Gao Ying, Hayes Richard B, Huang Wen-Yi, Caporaso Neil E, Burdette Laurie, Yeager Meredith, Chanock Stephen J, Berndt Sonja |
|
Interaction between XRCC1 polymorphisms and intake of long-term stored rice in the risk of esophageal squamous cell carcinoma: a case-control study.
Biomedical and environmental sciences : BES 2011 Jun 24 (3): 268-74. Yu Hongjie, Fu Chaowei, Wang Jianming, Xue Hengchuan, Xu Bi |
|
Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.
Cancer chemotherapy and pharmacology 2011 Jun 67 (6): 1323-31. Hong Junshik, Han Sae-Won, Ham Hye Seon, Kim Tae-Yong, Choi In Sil, Kim Byung-Su, Oh Do-Youn, Im Seock-Ah, Kang Gyeong Hoon, Bang Yung-Jue, Kim Tae-Y |
|
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.
The pharmacogenomics journal 2011 Jun 11 (3): 214-26. Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V, Sigon R, De Mattia E, Friso M L, Biason P, Visentin M, Nitti D, Toffoli |
|
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.
BMC cancer 2011 May 11 (1): 1. Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Phillips S, Powell M, Montgomery EA, Hafez MJ, Offer SM, Liu G, Meltzer SJ, Wu X, Forastiere AA, Benson AB, Kleinberg LR, Gibson MK |
|
Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 May 22 (5): 1147-53. Pander J, Wessels J A M, Gelderblom H, van der Straaten T, Punt C J A, Guchelaar H |
|
Association between genetic polymorphisms related to DNA repair or xenobiotic pathways and gastric premalignant conditions.
Anticancer research 2011 Apr 31 (4): 1459-65. Tahara Tomomitsu, Shibata Tomoyuki, Nakamura Masakatsu, Yamashita Hiromi, Yoshioka Daisuke, Okubo Masaaki, Yonemura Joh, Kamiya Yoshio, Ishizuka Takamitsu, Nakagawa Yoshihito, Nagasaka Mitsuo, Iwata Masami, Hirata Ichiro, Arisawa Tomiya |
|
Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population.
Cancer epidemiology 2011 Apr 35 (2): 170-4. Yuan Tao, Deng Shaoli, Chen Ming, Chen Wei, Lu Weiping, Huang Hengliu, Xia |
|
Polymorphisms of DNA repair and xenobiotic genes predispose to CpG island methylation in non-neoplastic gastric mucosa.
Helicobacter 2011 Apr 16 (2): 99-106. Tahara Tomomitsu, Shibata Tomoyuki, Nakamura Masakatsu, Okubo Masaaki, Yamashita Hiromi, Yoshioka Daisuke, Yonemura Joh, Ishizuka Takamitsu, Hirata Ichiro, Arisawa Tomiya |
|
Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis.
Carcinogenesis 2011 Mar 32 (3): 336-42. Liu Li, Wu Chen, Wang Ying, Zhong Rong, Wang Feng, Zhang Xuemei, Duan Shengyu, Lou Jiao, Yu Dianke, Tan Wen, Yuan Jing, Wu Tangchun, Nie Shaofa, Miao Xiaoping, Lin Dongx |
|
Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.
Pharmacogenomics 2011 Mar 12 (3): 433-42. Lamas Maria J, Duran Goretti, Balboa Emilia, Bernardez Beatriz, Touris Manuel, Vidal Yolanda, Gallardo Elena, Lopez Rafael, Carracedo Angel, Barros Francis |
|
Effect of genetic polymorphisms related to DNA repair and the xenobiotic pathway on the prognosis and survival of gastric cancer patients.
Anticancer research 2011 Feb 31 (2): 705-10. Tahara Tomomitsu, Shibata Tomoyuki, Nakamura Masakatsu, Yamashita Hiromi, Yoshioka Daisuke, Okubo Masaaki, Yonemura Joh, Ishizuka Takamitsu, Maruyama Naoko, Kamano Toshiaki, Kamiya Yoshio, Fujita Hiroshi, Nakagawa Yoshihito, Nagasaka Mitsuo, Iwata Masami, Yamada Hideto, Hirata Ichiro, Arisawa Tomiya |
|
X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
American journal of epidemiology 2011 Feb 173 (4): 363-75. Xue Huiping, Ni Peihua, Lin Bing, Xu Hong, Huang Ga |
|
[Interaction between polymorphisms in NQO1(C609T) and XRCC1(G28152A) and their correlation with smoking on gastric cancer].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2011 Jan 32 (1): 5-8. Chen Dao-jun, Ding Rui, Cao Wei, Ye Dong-qi |
|
[Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy].
Zhonghua yi xue za zhi 2011 Jan 91 (4): 256-9. Liu Yong-ping, Ling Yang, Zhang Ya-ping, Liu Bao-r |
|
Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy.
Pharmacogenetics and genomics 2011 Jan 21 (1): 18-25. Huang Ming-Yii, Huang Meng-Lin, Chen Ming-Jenn, Lu Chien-Yu, Chen Chin-Fan, Tsai Pei-Chien, Chuang Shih-Chang, Hou Ming-Feng, Lin Shiu-Ru, Wang Jaw-Yu |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: